EUVIMEDEUVIMED entdecken
Crossref

99m Tc‐tricarbonyl labeling of paclitaxel as an antimicrotubule agent and its evaluation in B16‐F10 melanoma tumor‐bearing mice

Mostafa Erfani, Zahra Shabani, Mojtaba Shamsaei, Seyed Pezhman Shirmardi, Mohammad Shafiei

Journal of Labelled Compounds and Radiopharmaceuticals · 2016-11 · 59 (13) · 582-588

DOI: 10.1002/jlcr.3468 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals, online erschienen am 26.10.2016. Verfasst von Mostafa Erfani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Application Research School, Nuclear Science and Technology Research Institute (NSTRI), Tehran, Iran. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the present study paclitaxel (taxol) was labeled with [ 99m Tc(CO) 3 (H 2 O) 3 ] + core. Labeling was optimized, and radiochemical analysis was determined by thin layer chromatography and high performance liquid chromatography. Radiocomplex was evaluated and verified further as a tumor characterization agent in B16‐F10 melanoma tumor‐bearing mice. The [ 99m Tc(CO) 3 (H 2 O) 3 ] + ‐paclitaxel complex with high specific activity (0.77 GBq/μmol) and labeling yield (96.8 ± 1.3) was obtained. No decrease in labeling was observed up to 6 hours, and the stability of the radiocomplex was found adequate. Our main achievement was high accumulation of radiolabeled paclitaxel in tumor (4.51 ± 0.65 percentage injected dose per gram [%ID/g] at 2‐h postinjection) followed by significant reduction (1.86 ± 0.27%ID/g) at 4‐hour postinjection. Because paclitaxel is a substrate for multidrug resistance, 99m Tc‐tricarbonyl‐paclitaxel imaging would be useful for tumor characterization rather than tumor detection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnimalsCell Line, TumorDrug StabilityHumansIsotope LabelingMelanoma, ExperimentalMiceMicrotubulesOrganotechnetium CompoundsPaclitaxelRadiochemistryTissue Distribution

Stichwörter der Autor:innen

99mTc(CO)3 coreimaginglabelingmelanoma tumorpaclitaxel

Substanzen

Organotechnetium CompoundsPaclitaxel

Autor:innen und Institutionen

  • Radiation Application Research School, Nuclear Science and Technology Research Institute (NSTRI), Tehran, Iran.
  • Faculty of Nuclear engineering and Physics, Amirkabir University of Technology, Tehran, Iran.

Zitieren

APA

Erfani, M., Shabani, Z., Shamsaei, M., Shirmardi, S. P., & Shafiei, M. (2016). 99m Tc‐tricarbonyl labeling of paclitaxel as an antimicrotubule agent and its evaluation in B16‐F10 melanoma tumor‐bearing mice. Journal of Labelled Compounds and Radiopharmaceuticals, 59(13), 582-588. https://doi.org/10.1002/jlcr.3468

Vancouver

Erfani M, Shabani Z, Shamsaei M, Shirmardi SP, Shafiei M. 99m Tc‐tricarbonyl labeling of paclitaxel as an antimicrotubule agent and its evaluation in B16‐F10 melanoma tumor‐bearing mice. Journal of Labelled Compounds and Radiopharmaceuticals. 2016;59(13):582-588. doi:10.1002/jlcr.3468

BibTeX
@article{Erfani2016,
  author = {Erfani, Mostafa and Shabani, Zahra and Shamsaei, Mojtaba and Shirmardi, Seyed Pezhman and Shafiei, Mohammad},
  title = {99m Tc‐tricarbonyl labeling of paclitaxel as an antimicrotubule agent and its evaluation in B16‐F10 melanoma tumor‐bearing mice},
  journal = {Journal of Labelled Compounds and Radiopharmaceuticals},
  year = {2016},
  volume = {59},
  number = {13},
  pages = {582--588},
  doi = {10.1002/jlcr.3468}
}
Kostenlos starten →